# Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia

> **NCT00231101** · NA · UNKNOWN · sponsor: **Arthur P. Noyes Research Foundation** · enrollment: 40 (—)

## Conditions studied

- Smoking Behavior in Schizophrenia

## Interventions

- **DRUG:** Quetiapine

## Key facts

- **NCT ID:** NCT00231101
- **Lead sponsor:** Arthur P. Noyes Research Foundation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 40 (—)
- **Last updated:** 2006-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231101, "Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00231101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*